Австралия - английски - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - nebivolol hydrochloride, quantity: 5.45 mg (equivalent: nebivolol, qty 5 mg) - tablet - excipient ingredients: maize starch; polysorbate 80; hypromellose; lactose monohydrate; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose - nebivolol is indicated: to treat essential hypertension; to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - nebivolol hydrochloride, quantity: 1.36 mg (equivalent: nebivolol, qty 1.25 mg) - tablet - excipient ingredients: croscarmellose sodium; magnesium stearate; polysorbate 80; maize starch; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; lactose monohydrate - nebivolol is indicated: to treat essential hypertension; to treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - nebivolol hydrochloride - oral tablet - 10mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

medreich plc - nebivolol hydrochloride - oral tablet - 5mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - nebivolol hydrochloride - oral tablet - 2.5mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - nebivolol hydrochloride - oral tablet - 5mg

САЩ - английски - NLM (National Library of Medicine)

modavar pharmaceuticals llc - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies ( 14.1 ) ]. nebivolol may be used alone or in combination with other antihypertensive agents [see drug interactions ( 7 )]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as

САЩ - английски - NLM (National Library of Medicine)

cadila pharmaceuticals limited - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies ( 14.1 ) ]. nebivolol may be used alone or in combination with other antihypertensive agents [see drug interactions ( 7 )]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as

САЩ - английски - NLM (National Library of Medicine)

lifestar pharma llc - nebivolol hydrochloride (unii: jgs34j7l9i) (nebivolol - unii:030y90569u) - nebivolol tablets are indicated for the treatment of hypertension, to lower blood pressure [see clinical studies (14.1)]. nebivolol tablets may be used alone or in combination with other antihypertensive agents [see drug interactions (7)]. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including the class to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with nebivolol tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelin

Ирландия - английски - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - nebivolol hydrochloride - tablet - nebivolol